These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3063531)

  • 1. Reduced insulin removal and erythrocyte insulin binding in obese children.
    Knip M; Lautala P; Puukka R
    Eur J Pediatr; 1988 Dec; 148(3):233-7. PubMed ID: 3063531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte insulin binding in obese children and adolescents.
    Kappy MS; Plotnick L
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1440-6. PubMed ID: 7002954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased insulin removal contributes to hyperinsulinemia in obesity.
    Faber OK; Christensen K; Kehlet H; Madsbad S; Binder C
    J Clin Endocrinol Metab; 1981 Sep; 53(3):618-21. PubMed ID: 7021583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in erythrocyte insulin binding in offspring of conjugal non-insulin-dependent diabetic parents.
    Ramachandran A; Susheela L; Mohan V; Kuzhali DA; Viswanathan M
    Diabetes Res Clin Pract; 1988 Oct; 5(4):241-7. PubMed ID: 3069407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?
    Bonora E; Zavaroni I; Bruschi F; Alpi O; Pezzarossa A; Guerra L; Dall'Aglio E; Coscelli C; Butturini U
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1121-7. PubMed ID: 6386838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of body weight, hyperinsulinemia and oral glucose load on serum C-peptide/insulin molar ratio.
    Okada N; Kobayashi M; Ohtsuka H; Shigematsu S; Nagasawa Y; Komatsu M; Aizawa T; Yamada T
    Horm Metab Res; 1992 Sep; 24(9):429-33. PubMed ID: 1427614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered basal C-peptide/insulin molar ratios in obese patients with fatty liver.
    Inokuchi T; Watanabe K; Kameyama H; Orita M
    Jpn J Med; 1988 Aug; 27(3):272-6. PubMed ID: 3057268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
    Robertson DA; Singh BM; Nattrass M
    Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation between glucose tolerance and insulin binding to circulating monocytes in obese children.
    Kida K; Watanabe N; Fujisawa Y; Goto Y; Matsuda H
    Pediatrics; 1982 Oct; 70(4):633-7. PubMed ID: 6750546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin metabolism in hypothalamic obesity.
    Blatniczky L; Kautzky L; Péter F
    Exp Clin Endocrinol; 1990 Sep; 96(1):83-9. PubMed ID: 2279530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
    Gragnoli G; Signorini AM; Tanganelli I; Martinelli G
    Boll Soc Ital Biol Sper; 1979 Mar; 55(6):564-70. PubMed ID: 399187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of insulin on the raised plasma fibronectin concentration in human obesity.
    Dejgård A; Andersen T; Gluud C
    Acta Med Scand; 1986; 220(3):269-72. PubMed ID: 3535400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients.
    Osei K; Falko JM; O'Dorisio TM; Adam DR
    Diabetes Care; 1984; 7(5):471-5. PubMed ID: 6389061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal insulin secretion and erythrocyte insulin binding in preterm and term newborn infants.
    Knip M; Puukka R; Lautala P; Leppilampi M; Puukka M
    Biol Neonate; 1983; 43(3-4):172-80. PubMed ID: 6344928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo insulin sensitivity and insulin binding to erythrocytes in children: insulin resistance in obese children.
    Asayama K; Amemiya S; Kato K; Shimizu M
    Endocrinol Jpn; 1982 Oct; 29(5):575-81. PubMed ID: 6133745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
    Garvey WT; Olefsky JM; Rubenstein AH; Kolterman OG
    Diabetes; 1988 May; 37(5):590-9. PubMed ID: 3282946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin binding to erythrocytes in diabetic patients.
    Okamoto M; Kuzuya H; Seino Y; Ikeda M; Imura H
    Endocrinol Jpn; 1981 Apr; 28(2):169-73. PubMed ID: 7030723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity.
    Le Stunff C; Bougnères P
    Diabetes; 1994 May; 43(5):696-702. PubMed ID: 8168647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease.
    Mahabeer S; Jialal I; Norman RJ; Naidoo C; Reddi K; Joubert SM
    Horm Metab Res; 1989 Sep; 21(9):502-6. PubMed ID: 2684835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.